COMP <GO>
PYXS vs SLGL // REVENUE GROWTH (YOY)
Pyxis Oncology Inc. (NASDAQ) VS. Sol-Gel Technologies Ltd. (NASDAQ) • 15-METRIC TALLY: PYXS 0
— SLGL 6
▲ REVENUE GROWTH (YOY) LEADER: SLGL
LAST: $1.69 (-6.63%) • MKT CAP: $202.1M
revenue-growth
-14.20%
LAST: $65.69 (-3.89%) • MKT CAP: $215.1M
revenue-growth
68.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PYXS VS. SLGL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PYXS | SLGL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 82.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 0.12% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -38.90% | -21.10 | SLGL | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -31.60% | -28.40 | SLGL | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -14.20% | 68.00% | -82.20 | SLGL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 8.54 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 6/9 | -3.00 | SLGL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.4 | 44.4 | -7.00 | SLGL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $202.1M | $215.1M | -$13.0M | SLGL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PYXS REV | SLGL REV | PYXS GROSS % | SLGL GROSS % | PYXS FCF | SLGL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.9M | $19.4M | 82.8% | — | -$63.5M | $275.0K |
| FY 2024 | $16.1M | $11.5M | 97.1% | — | -$57.9M | -$13.9M |
| FY 2023 | $230.1M | $1.6M | — | — | -$70.7M | -$17.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PYXS // BETA —
SLGL // BETA —